共 1 条
[1]
New anilinophthalazines as potent and orally well absorbed inhibitors of the VEGF receptor tyrosine kinases useful as antagonists of tumor-driven angiogenesis
[J].
Bold, G
;
Altmann, KH
;
Frei, J
;
Lang, M
;
Manley, PW
;
Traxler, P
;
Wietfeld, B
;
Brüggen, J
;
Buchdunger, E
;
Cozens, R
;
Ferrari, S
;
Furet, P
;
Hofmann, F
;
Martiny-Baron, G
;
Mestan, J
;
Rösel, J
;
Sills, M
;
Stover, D
;
Acemoglu, F
;
Boss, E
;
Emmenegger, R
;
Lässer, L
;
Masso, E
;
Roth, R
;
Schlachter, C
;
Vetterli, W
;
Wyss, D
;
Wood, JM
.
JOURNAL OF MEDICINAL CHEMISTRY,
2000, 43 (12)
:2310-2323

Bold, G
论文数: 0 引用数: 0
h-index: 0
机构:
NOVARTIS Pharma AG, Oncol Res, CH-4002 Basel, Switzerland NOVARTIS Pharma AG, Oncol Res, CH-4002 Basel, Switzerland

Altmann, KH
论文数: 0 引用数: 0
h-index: 0
机构: NOVARTIS Pharma AG, Oncol Res, CH-4002 Basel, Switzerland

Frei, J
论文数: 0 引用数: 0
h-index: 0
机构: NOVARTIS Pharma AG, Oncol Res, CH-4002 Basel, Switzerland

Lang, M
论文数: 0 引用数: 0
h-index: 0
机构: NOVARTIS Pharma AG, Oncol Res, CH-4002 Basel, Switzerland

Manley, PW
论文数: 0 引用数: 0
h-index: 0
机构: NOVARTIS Pharma AG, Oncol Res, CH-4002 Basel, Switzerland

Traxler, P
论文数: 0 引用数: 0
h-index: 0
机构: NOVARTIS Pharma AG, Oncol Res, CH-4002 Basel, Switzerland

Wietfeld, B
论文数: 0 引用数: 0
h-index: 0
机构: NOVARTIS Pharma AG, Oncol Res, CH-4002 Basel, Switzerland

Brüggen, J
论文数: 0 引用数: 0
h-index: 0
机构: NOVARTIS Pharma AG, Oncol Res, CH-4002 Basel, Switzerland

Buchdunger, E
论文数: 0 引用数: 0
h-index: 0
机构: NOVARTIS Pharma AG, Oncol Res, CH-4002 Basel, Switzerland

Cozens, R
论文数: 0 引用数: 0
h-index: 0
机构: NOVARTIS Pharma AG, Oncol Res, CH-4002 Basel, Switzerland

Ferrari, S
论文数: 0 引用数: 0
h-index: 0
机构: NOVARTIS Pharma AG, Oncol Res, CH-4002 Basel, Switzerland

Furet, P
论文数: 0 引用数: 0
h-index: 0
机构: NOVARTIS Pharma AG, Oncol Res, CH-4002 Basel, Switzerland

Hofmann, F
论文数: 0 引用数: 0
h-index: 0
机构: NOVARTIS Pharma AG, Oncol Res, CH-4002 Basel, Switzerland

Martiny-Baron, G
论文数: 0 引用数: 0
h-index: 0
机构: NOVARTIS Pharma AG, Oncol Res, CH-4002 Basel, Switzerland

Mestan, J
论文数: 0 引用数: 0
h-index: 0
机构: NOVARTIS Pharma AG, Oncol Res, CH-4002 Basel, Switzerland

Rösel, J
论文数: 0 引用数: 0
h-index: 0
机构: NOVARTIS Pharma AG, Oncol Res, CH-4002 Basel, Switzerland

Sills, M
论文数: 0 引用数: 0
h-index: 0
机构: NOVARTIS Pharma AG, Oncol Res, CH-4002 Basel, Switzerland

Stover, D
论文数: 0 引用数: 0
h-index: 0
机构: NOVARTIS Pharma AG, Oncol Res, CH-4002 Basel, Switzerland

Acemoglu, F
论文数: 0 引用数: 0
h-index: 0
机构: NOVARTIS Pharma AG, Oncol Res, CH-4002 Basel, Switzerland

Boss, E
论文数: 0 引用数: 0
h-index: 0
机构: NOVARTIS Pharma AG, Oncol Res, CH-4002 Basel, Switzerland

Emmenegger, R
论文数: 0 引用数: 0
h-index: 0
机构: NOVARTIS Pharma AG, Oncol Res, CH-4002 Basel, Switzerland

Lässer, L
论文数: 0 引用数: 0
h-index: 0
机构: NOVARTIS Pharma AG, Oncol Res, CH-4002 Basel, Switzerland

Masso, E
论文数: 0 引用数: 0
h-index: 0
机构: NOVARTIS Pharma AG, Oncol Res, CH-4002 Basel, Switzerland

Roth, R
论文数: 0 引用数: 0
h-index: 0
机构: NOVARTIS Pharma AG, Oncol Res, CH-4002 Basel, Switzerland

Schlachter, C
论文数: 0 引用数: 0
h-index: 0
机构: NOVARTIS Pharma AG, Oncol Res, CH-4002 Basel, Switzerland

Vetterli, W
论文数: 0 引用数: 0
h-index: 0
机构: NOVARTIS Pharma AG, Oncol Res, CH-4002 Basel, Switzerland

Wyss, D
论文数: 0 引用数: 0
h-index: 0
机构: NOVARTIS Pharma AG, Oncol Res, CH-4002 Basel, Switzerland

Wood, JM
论文数: 0 引用数: 0
h-index: 0
机构: NOVARTIS Pharma AG, Oncol Res, CH-4002 Basel, Switzerland